Back to Search
BRIAN BERGSTROM, DO, MA
DO, MA
Surgery Physician
NPI: 1033501531Individual
Specialties, Licenses & Credentials
Research & Publications (15)
Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study.
PMID 18334511·Ann Oncol·2008
3-trial
Impact of altering randomization intervals on precision of measurement and item exposure.
PMID 18480512·J Appl Meas·2008
8-other
Aspartame decreases evoked extracellular dopamine levels in the rat brain: an in vivo voltammetry study.
PMID 17976663·Neuropharmacology·2007
7-preclinical
Phase II, randomized, multicenter, comparative study of peginterferon-alpha-2a (40 kD) (Pegasys) versus interferon alpha-2a (Roferon-A) in patients with treatment-naïve, chronic-phase chronic myelogenous leukemia.
PMID 17454589·Leuk Lymphoma·2007
3-trial
Randomized dose-escalation study evaluating peginterferon alfa-2a in patients with metastatic malignant melanoma.
PMID 16505439·J Clin Oncol·2006
3-trial
Intravenous ibandronate does not affect time to renal function deterioration in patients with skeletal metastases from breast cancer: phase III trial results.
PMID 16882128·Eur J Cancer Care (Engl)·2006
3-trial
Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions.
PMID 15479378·Haemophilia·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 101 S MOORE AVE
CLAREMORE, OK 74017 - Phone
- (918) 342-6200
Quick Facts
- NPI
- 1033501531
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 15
Are you this provider?
Claim Your Profile